Background {#Sec1}
==========

It might be easily thought out that tumor-related factors such as tumor size, lymphatic invasion, and venous invasion could be an indicator for progressive potential of malignant tumors \[[@CR1]--[@CR3]\]. However, except for stage of the tumor, there have not been any criteria using histopathological tumor-related factors to determine the outcome of the patients with gastric carcinoma.

Histopathological type is an important prognosis factor, it is also to determine the extent of surgical resection and formulated the basis for reasonable surgical plan \[[@CR4], [@CR5]\]. It plays an important role in prognostic score for a variety of tumors, such as Gleason score for prostate cancer \[[@CR6]\], Child-pugh classification for hepatocellular carcinoma \[[@CR7]\], SBR, WHO score for breast cancer \[[@CR8]\], but the prognostic effect of histopathology has never been reported in gastric cancer. Moreover, there is not any effective way to identify the prognosis of early gastric cancer.

The coexistence of different histological types of gastric cancer determines the the complex characteristics of clinical behavior and prognosis, the mixed histological type accounted for over 25% of all gastric cancer \[[@CR9], [@CR10]\]. Since major diagnostic principles are used, the highly heterogeneous histological features of gastric cancer were ignored, tumor biological behavior and prognostic value of minor histological type were coved up \[[@CR11]\]. We currently evaluated the prognostic significance of WHO histological classification of gastric cancer with a new histological scoring method, which makes the histopathological variable to be an independent prognostic factor.

In this study, we attempted to evaluate the histological characteristics and establish simple criteria using the results of histopathological tumor-related factors to predict prognosis of patients with gastric carcinoma.

Methods {#Sec2}
-------

All patients with gastric cancer who underwent surgery at the Department of Surgical Oncology, First Hospital of China Medical University, during January 1980 to December 2006 were entered into a prospectively maintained database. Ethical approval for this research was obtained from the Research Ethics Committee of China Medical University, China. In total, 1077 patients underwent D2 lymphadenectomy and achieved radical (R0) resection for histologically proven gastric carcinoma. Follow-up was complete for the entire study population to June 2005. Among them, 24 died in the postoperative period and 43 were lost to follow-up. Thus, 145 patients were excluded. Of the remaining 932 patients, Median and mean follow-up period were 31 and 54 months (range: 3--313 months), respectively. Patients were treated exclusively by total or subtotal gastrectomy with lymphadenectomy, according to tumor location, adjuvant therapy or postoperative chemotherapy was not administered to any patient. Cancer-specific survival was calculated from the date of primary surgical resection to the date of gastric cancer associated death or to the date of recorded cancer progression. Tumor invasion (T), lymph node involvement (N) and TNM stage were classified according to the 7^th^ UICC/AJCC (2012) staging systems.

Histological grading {#Sec3}
--------------------

According to highly heterogeneous histological features and WHO classification of gastric cancer, we propose the novel histological grading system. Aiming to develop and validate the scoring system, the following statistical computing methodologies were applied in the order indicated:According to the previous studies of histological differentiation and malignant degree of gastric carcinoma, non-mucinous adenocarcinoma (papillary adenocarcinoma and high, medium and low differentiated tubular adenocarcinoma) were assigned as 1--3 points, respectively. Mucinous adenocarcinoma was assigned as 3 points, signet ring cell carcinoma was assigned as 4 points, undifferentiated carcinoma was assigned as 4 points, a special type of stomach cancer as 4 points (these score still needs further refinement) (Table  [1](#Tab1){ref-type="table"}).(2) The total score of gastric carcinoma was summed by the original score of the primary histological type and secondary type of gastric carcinoma. Then the total score was divided by the number of histological types to calculate the final score (The mean of the total score). If it was composed of three or more histological type of gastric tissues, The scores will aggregate all score of histological type, then divideded by the number of histological types to get the final score, as presented in Figure  [1](#Fig1){ref-type="fig"}. If the carcinoma was composed of a pure histological type (All tumors were constituted by the primary type), the score remains the final score.Table 1**Histological grading points of different subtypes of gastric carcinoma**Gastric carcinomaScorePapillary carcinoma1Tubular carcinoma  Well-differentiated1  Medium-differentiated2  Poorly-differentiated3Mucinous gastric carcinoma3signet-ring cell4Undifferentiated gastric carcinoma5Special type gastric carcinoma4  Adeno-squamous carcinoma  Squamous cell carcinoma  Sarcomatoid type gastric cancer  Liver adenocarcinoma  Micro papillary carcinoma  Neuroendocrine carcinoma  Eosinophilic cell carcinomaFigure 1**Mixed histological type of gastric cancer in WHO classification. (A)** high differentiated tubular adenocarcinoma mixed with mucinous adenocarcinoma, final score: (1 + 3)/2 = 2, **(B)** medium differentiated tubular adenocarcinoma mixed with mucinous adenocarcinoma, final score: (2 + 3)/2 = 2.5 **(C)** high differentiated tubular adenocarcinoma mixed with signet ring cell carcinoma and mucinous adenocarcinoma, final score: (1 + 3 + 4)/3 = 2.7, **(D)** high differentiated mixed with undifferentiated gastric cancer, final score: (1 + 5)/2 = 3.

(3)Histological grading stage (H Stage) was divided into four groups according to their scores, as follows: H1 (≤2 points), H2 (2--3 points), H3 (3--4 points) and H4 (4--5 points).

Statistical analysis {#Sec4}
--------------------

Each variable was used as an independent variable in a Cox proportional hazards analysis run using the Kaplan-Meier method. This was done to screen the variables for later inclusion in a multivariable model. To be included in the multivariable analysis, a variable had to be significant at α of 0.1 for the Wald test. This was a test of the null hypothesis that the coefficient for all levels of the variable of interest was equal to zero.

All significant variables of the univariate analysis were included in the first run of a multivariable Cox proportionate hazard regression. In subsequent Cox regressions, significantly different variables in their hazard ratios were remained sequentially based on the z-statistic for the individual levels of each categorical variable. To remain in the final model, a variable had to be significant at α of 0.05 at all levels.

Results {#Sec5}
=======

As stated above, the study included 932 patients undergoing gastrectomy for gastric carcinoma from 1980 to 2005. All patients followed until death or for a maximum 313 months. The overall 5-year survival rate was 41.1%. Adjuvant and chemotherapy treatment was rarely applied in this series. The frequencies of patient characteristics and epidemiological results are summarized in Table  [2](#Tab2){ref-type="table"}.Table 2**Univariate analysis of the prognostic factors for patients with gastric cancer in overall and early stage**VariablesOverallEarly stageCasesn(%)5-year OS(%)P valueCasesn(%)5-year OS(%)P valueGender9320.3119082.20.07  Male66971.837.86572.286.2  Female26328.243.12527.872.0Age(years)0.0620.32  ≤6553357.234.36673.383.3  \>6539942.843.02426.779.2Size\<0.0010.714  ≤4 cm22424.059.25763.382.5  \>4 cm70876.033.03336.781.8Location\<0.0010.149  Lower67272.142.17583.385.3  Middle9910.637.6910.066.7  Upper11512.336.566.766.7  Entire464.925.400.00.0Macroscopic Type\<0.001  Early stage9010.781.0  Borrmann I302.142.1  Borrmann II14515.640.7  Borrmann III61465.934.2  Borrmann IV525.613.7Lauren grade0.0030.218  Intestinal45548.850.43842.286.5  Diffuse47751.237.15257.873.1Histologic type0.3340.263  Mixed-type27229.240.33741.161.3  Well-differentiated616.557.977.883.7  Medium-differentiated11212.043.788.953.9  Poorly-differentiated36539.237.53437.840.2  Mucinous586.238.611.1100.0  Signet-ring cell293.147.833.333.3  Undifferentiated303.221.400.00.0  Squamous cell50.525.000.00.0Histologic type 20.5040.958  Differentiated38040.837.65965.683.1  Undifferentiated55259.240.53134.480.6Histologic type 30.0320.016  Singal-type68473.339.35662.289.1  Mixed-type24626.439.33437.872.4Histologic Grading\<0.001\<0.001  1636.882.53030.093.3  235237.762.04550.088.6  339942.826.21718.978.6  411812.66.811.10.0T Stage\<0.001  T1909.782.2  T218519.850.8  T341844.836.5  T423925.619.0N Stage\<0.0010.06  N028830.963.86572.286.2  N116818.043.71314.476.9  N218920.334.01011.170.0  N328722.512.222.250.0Lymphovascular invasion0.032  Negative20822.340.7  Positive72477.722.6Peritoneal metastasis0.022  Absent88988.939.8  Present4311.119.5Hepatic metastasis0.014  Absent87890.338.7  Present549.616.8

Difference of survival reflected by tumor-related factors such as tumor size, tumor depth, lymph node metastasis was shown in Table  [3](#Tab3){ref-type="table"}. Compared to the pure histological type, mixed histological type gastric cancer was significant associated with tumor size, lymph node metastasis and depth of invasion (all P \< 0.05). All the gastric cancer patients were stratified by advanced and early stage. The 5-year survival rates of advanced and early gastric cancer patients with mixed form were 40.8% and 83.5% respectively, which were lower than those with pure form (50.0% and 95.8%, P \< 0.01) ( Figure  [2](#Fig2){ref-type="fig"}).Table 3**Relationship between the prognostic factors and histological types for patients with gastric cancer**VariablesCases 932Pure type 684 (73.61)Mixed type 246 (26.39)χ2P valueGender0.5320.466  Male669488181  Female26319865Age(years)0.0390.843  ≤65533391142  \>65399295104Size\<0.0010.983  ≤4 cm22416559  \>4 cm708521187Location0.0810.96  Lower672495178  Middle9910338  Upper1158830  Entire46Macroscopic Type11.1730.018  Early stage906634  Borrmann I30137  Borrmann II14511926  Borrmann III614453161  Borrmann IV523517Lauren grade0.1890.003  Intestinal455368128  Diffuse477318118T Stage9.629\<0.001  T1905634  T218514045  T341832197  T423916970N Stage3.0430.551  N028821375  N116813137  N218913554  N328720780Lymphovascular invasion8.7940.038  Negative208378121  Positive724300124Peritoneal metastasis10.322\<0.001  Absent889672215  Present431231Hepatic metastasis11.523\<0.001  Absent878667209  Present541737Figure 2**The 5-year survival rates of gastric cancer patients with mixed form were lower than those with pure form, especially for early stage. (A)** Survival rates of all gastric cancer patients with mixed form were 48.2% and single form were 53.3%, P = 0.305. **(B)** Survival rates of early gastric cancer patients with mixed form were 83.5% and single form were 95.8%, P \< 0.01. **(C)** Survival rates of early gastric cancer patients with mixed form were 40.8% and single form were 50.0%, P = 0.037.

Patients stratified by Histological grading of 214 (55.9%), 182 (28.4%), 492 (15.7%) and 44 (28.4%) defined Histological stage I, II, III and IV, respectively. Statistically significant difference with stratification of early and advanced stage could be observed between patients with the histological grading score, respectively. Mixed histological type gastric cancer had worse prognosis in early and advanced stage (Table  [2](#Tab2){ref-type="table"}). No significant difference was observed regarding gender and age of the patients. Significant correlation was observed between H grading scores and all of the tumor-related factors (Table  [4](#Tab4){ref-type="table"}).The T, N, and TNM stage are the best classification system to classify overall survival of patients with gastric carcinoma, however, there is no effective methodology to evaluate the prognosis of early stage. The 5-year survival rates of gastric cancer patients stratified by histological grading showed there is no superiority compared to T stage and N stage, but the 5-year survival rates of patients with early stage stratified by histological grading was much better than N stage in predicting the prognosis of the early stages, P \< 0.01. Significant difference could be observed in survival curves between the early and advanced stage for the same patients, respectively (Figure  [3](#Fig3){ref-type="fig"}).Table 4**Comparison of relationship between Histological grading and prognositic factors**Histological gradingPVariablesH1 (≤2)H2 (2--3)H3 (3--4)H4 (4--5)Size\<0.001  ≤4 cm61391177  \>4 cm15314337537Location  Lower15013035835  Middle3425766  Upper3027583  EntireMacroscopic Type\<0.001  Early stage3118492  Borrmann I10271  Borrmann II4333636  Borrmann III12712333430  Borrmann IV36385Lauren grade\<0.001  Intestinal1691271946  Diffuse455529838Histologic type\<0.001  Differentiated164141723  Un-differentiated504142041Depth of tumor\<0.001  T13017421  T24636958  T3928922314  T4464013221Node metastasis\<0.001  N087551379  N14237836  N24440969  N3415017620Lymphovascular invasion\<0.001  Negative14510424010  Positive777624935Peritoneal metastasis  Absent889  Present43Hepatic metastasis  Absent878  Present54Figure 3**The 5-year survival rates of gastric cancer patients stratified by histological grading. (A)** showed there is no superiority compared to N stage **(B)** and T stage **(C)**, but the 5-year survival rates of patients with early stage stratified by histological grading **(D)** was much better than N stage **(E)** in predicting the prognosis of the early stages, P \< 0.01. Significant difference could be observed in survival curves between the early and advanced stage for the same patients, respectively.

The multivariate Cox stepwise proportional hazard model identified Macroscopic type (HR, 1.226, P \<0.001), Histological grading (HR, 1.316, P \<0.001), T stage (HR, 1.340, P \<0.001), N stage (HR, 1.425, P \<0.001) as independent predictors of prognosis. In the early gastric cancer, Histological grading (HR, 1.533, P \<0.001), Tumor size (HR, 1.412, P \<0.001) and N stage (HR, 1.213, P \<0.001) as independent predictors of prognosis, histological grading were proved to be the highest HR (Table  [5](#Tab5){ref-type="table"}).Table 5**Mutivariate analysis of the prognostic factors for patients with gastric cancer in overall and early stage**VariablesOverallEarly stageHR95% CIP valueHR95% CIP valueSize1.2200.958-1.5540.1071.4121.026-1.545\<0.001Macroscopic type1.2261.086-1.385\<0.0011.3650.922-1.4630.103Lauren grade1.1810.894-1.0760.6841.1330.754-1.0420.725Histologic type1.1360.764-1.3520.7221.1360.764-1.3520.722Histologic grading1.3161.182-1.465\<0.0011.5330.838-1.734\<0.001N Stage1.4251.328-1.529\<0.0011.2131.096-1.4160.036T Stage1.3401.181-1.522\<0.001Distant metastasis1.2150.935-1.6500.116

Discussion {#Sec6}
----------

Generally, tumor stage composed of depth of tumor, lymph node metastasis, and distant metastasis, might account for the most powerful indicator for the prognosis in the majority of malignant tumors \[[@CR12]--[@CR15]\]. Conventional histopathological variables that have been correlated with prognosis of many malignant neoplasms plays an important role in prognostic score, such as Gleason score of prostate cancer, Child-pugh classification of hepatocellular carcinoma, SBR, WHO score of breast cancer \[[@CR8], [@CR16], [@CR17]\].

Nevertheless, for gastric cancer, separated from other cancers, the prognostic value of these factors has not been consistently recognized. It has been reported that there is no relationship between gastric histological type and prognosis, there is no comprehensive pathological conditions or anything about gastric histopathological differentiation in the reflection of gastric cancer staging and prognosis \[[@CR18]\].

However, the practical value of some of histopathological variables is limited due to complexity of gastric histological composition, coexistence of different malignancy subtypes and ambiguity of tumor biological behaviors \[[@CR19]\]. Despite their histological variability, usually one of four patterns predominates. The diagnosis is based on the predominant histological pattern \[[@CR20]\]. Histologically, most subtypes of carcinoma occur in early gastric cancer in either pure or mixed forms. We performed this study to compare pure or mixed gastric cancer forms of prognosis, The 5-year survival rates of advanced and early gastric cancer patients with mixed form were 40.8% and 83.5% respectively, which were lower than those with pure form (50.0% and 95.8%, P \< 0.01).

Proportion of mixed forms gastric cancer patients with N0 stage were significantly lower than with a pure type, patients of mixed type are more likely to lymph node metastasis. Mixed forms were significantly correlated with T stage, so patients were stratified into early and advanced stage, univariate analysis and survival curve showed 5 -year survival of mixed type of early gastric cancer was significantly lower than that that of a pure type, and there was little difference in the advanced stage.

With the histological grading score, there is significantly different between the 5-year survival curves of H Stage, prognosis of early gastric cancer could be identified obviously, which is not reflected in any other current classification. Indeed, statistically significant difference with so strict stratification was observed between patients with H Stage 1--4.

The T, N, or TNM classification system could exert an excellent ability to classify overall survival of patients with gastric carcinoma also in the current study. However, in early gastric cancers, only small mucosal (\<4 cm), superficial (\>4 cm) and PenA, PenB may have a low incidence of lymph node metastasis with good prognosis after surgery \[[@CR21]\]. There is no effective methodology to evaluate the prognosis of early gastric cancer. Our new histological grading provides a new tragedy to identify the prognosis of early gastric cancer.

Of course, TNM classification system could exert an excellent ability to classify survival of patients with gastric carcinoma also in the current study. Therefore, H grading system newly devised as well as TNM classification system could classify the prognosis of patients with gastric carcinoma with a strict stratification. This score system would provide objective information regarding the outcome of patients treated with curative resection for gastric carcinoma.

In conclusion, H Stage that can be utilized in the majority of the institutes would be quite simple criteria to predict prognosis of gastric carcinoma with a strict stratification.

Conclusions {#Sec7}
===========

The histological score that we developed in the research exert an excellent ability to classify survival of patients with gastric carcinoma, it could classify the prognosis of patients with gastric carcinoma with a strict stratification. The histological score is an independent factor of gastric cancer. It also provides a new strategy and parameter for evaluating the biological behavior and prognosis of gastric cancer.
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